EurekaMag.com logo
+ Translate

Evaluation of a continuous estrogen progestogen regimen for climacteric complaints


, : Evaluation of a continuous estrogen progestogen regimen for climacteric complaints. Maturitas 4(2): 95-102

Subjective complaints, endometrial histopathology, vaginal cytology and bleeding patterns were recorded in 26 patients treated with a continuous estrogen-progestogen regimen for 12 mo. A marked reduction of hot flushes and sweats were noted and the evaluation of endometrial specimens revealed that the mucosae were mostly inactive-atrophic. The karyopyknotic index proved to be a poor indicator of estrogenic activity. The number of recorded bleedings in the peri-menopausal women differed markedly from the post-menopausal women during treatment; they were very slight in the latter group. Even in those cases where bleeding occurred, the endometrial samples were atrophic. Vaginal bleeding seemed to be an unreliable indicator of endometrial histopathology. The present combination of hormones used in a continuous regimen is a good alternative for post-menopausal women in need of hormonal therapy.

(PDF 0-2 workdays service)

Accession: 005395027

PMID: 7121296

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Mattsson, L.A.; Cullberg, G.; Samsioe, G., 1984: A continuous estrogen-progestogen regimen for climacteric complaints. Effects on lipid and lipoprotein metabolism. The lipid composition of serum and the lipoprotein fractions, very low density lipoprotein (VLDL), low density lipoprotein (LDL) and high density lipoprotein (HDL) were determined in 26 peri- and postmenopausal women treated with a daily dose of 2...

Holst J.; Cajander S.; Von Schoultz B., 1987: Endometrial effects of a continuous percutaneous estrogen low dose oral progestogen regimen for climacteric complaints. Eleven post-menopausal women were followed up during continuous replacement therapy with percutaneous 17.beta.-oestradiol, 1.5 mg, opposed by oral levo-norgestrel, 30 .mu.g, daily. Endometrial biopsies were taken before and after 3 months of treat...

Mattsson, L.A.; Cullberg, G.; Samsioe, G., 1982: Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints. Subjective complaints, endometrial histopathology, vaginal cytology and bleeding patterns were recorded in 26 patients treated with a continuous oestrogen-progestogen regimen for 12 mth. A marked reduction of hot flushes and sweats were noted and...

Sporrong T.; Hellgren M.; Mattsson L.A.; Samsioe G., 1985: Four different regimens of continuous estrogen progestogen for climacteric complaints. Archives of Gynecology 237(SUPPL): 211

Holst, J.; Cajander, S.; von Schoultz, B., 1987: Endometrial effects of a continuous percutaneous oestrogen/low dose oral progestogen regimen for climacteric complaints. Eleven post-menopausal women were followed up during continuous replacement therapy with percutaneous 17 beta-oestradiol, 1.5 mg, opposed by oral levo-norgestrel, 30 micrograms, daily. Endometrial biopsies were taken before and after 3 months of t...

Mattsson, L.A.; Samsioe, G., 1985: Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen. Twenty-six peri- and postmenopausal women were treated with daily dose of 2 mg 17-beta-estradiol, 1 mg estriol and 1 mg norethisterone-acetate in a continuous regimen for 12 months. Clinical parameters such as vasomotor symptoms, bleeding patterns...

Mattsson, L.A.; Cullberg, G.; Samsioe, G., 1986: The relative fatty acid composition of serum lecithin and cholesterol ester: influence of an estrogen-progestogen regimen in climacteric women. The relative fatty acid compositions of serum lecithin and cholesterol ester were studied during continuous treatment with an estrogen/progestogen combination. All 26 women who participated suffered from climacteric complaints and were given one t...

Hovik P.; Sundsbak H.P.; Gassemyr M.; Sandvik A., 1989: Comparison of continuous and sequential estrogen progestogen treatment in women with climacteric symptoms. Continuous (Kliogest) and sequential (Trisequens) oestrogen-progestogen treatment were compared in a randomized, parallel, group study in women suffering from climacteric symptoms. The subjects were treated with Trisequens for 4 months prior to ra...

Mattsson, L.A.; Abrahamsson, L.; Cullberg, G.; Samsioe, G., 1983: Effects of a continuous estrogen-progestogen therapy for climacteric symptoms on circulating sex steroids and gonadotrophins. Twenty-six peri- and postmenopausal women with climacteric symptoms were given each day for 1 year a tablet containing 2 mg 17-beta-estradiol, 1 mg estriol and 1 mg norethisterone acetate. Blood samples were collected before, after 3 months and af...

Mattsson L A.; Abrahamsson L.; Cullberg G.; Samsioe G., 1983: Effects of a continuous estrogen progestogen therapy for climacteric symptoms on circulating sex steroids and gonadotropins. Twenty-six peri- and postmenopausal women with climacteric symptoms were given each day for 1 yr a tablet containing 2 mg 17.beta.-estradiol, 1 mg estriol and 1 mg norethisterone acetate. Blood samples were collected before, after 3 mo. and after...